Detalhe da pesquisa
1.
Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant.
Am J Transplant
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643944
2.
Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.
Cancer
; 129(5): 780-789, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571557
3.
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative.
Br J Haematol
; 200(3): 297-305, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454546
4.
Post-transplant lymphoproliferative disease in children, adolescents, and young adults.
Hematol Oncol
; 41 Suppl 1: 48-56, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294957
5.
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy.
Pediatr Blood Cancer
; 70(4): e30214, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36694431
6.
Durable remissions achieved with reinfusion of CD19-directed CAR-T despite failure to induce or maintain B-cell aplasia and single-center experience with reinfusion of tisagenlecleucel.
Pediatr Blood Cancer
; 70(5): e30271, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815392
7.
Tolerance of dinutuximab therapy for treatment of high-risk neuroblastoma in two patients with end-stage renal disease on dialysis.
Pediatr Blood Cancer
; 68(3): e28852, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33381917
8.
Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective.
Pediatr Blood Cancer
; 68(8): e29126, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019326
9.
Chimeric Antigen Receptor T Cell Therapy in Patients with Multiply Relapsed or Refractory Extramedullary Leukemia.
Biol Blood Marrow Transplant
; 26(11): e280-e285, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32755637
10.
Chimeric antigen receptor T-cell therapy in patients with neurologic comorbidities.
Pediatr Blood Cancer
; 67(4): e28199, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32020723
11.
EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects.
Pediatr Blood Cancer
; 67(3): e28126, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31850668
12.
A case of submandibular desmoplastic small round cell tumor: Diagnostic and management approaches to an atypical presentation of a rare tumor.
Pediatr Blood Cancer
; 67(4): e28178, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31925924
13.
Virus-Specific T Cells for the Treatment of Systemic Infections Following Allogeneic Hematopoietic Cell and Solid Organ Transplantation.
J Pediatric Infect Dis Soc
; 13(Supplement_1): S49-S57, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417086
14.
Cyclic AMP signaling inhibits megakaryocytic differentiation by targeting transcription factor 3 (E2A) cyclin-dependent kinase inhibitor 1A (CDKN1A) transcriptional axis.
J Biol Chem
; 287(23): 19207-15, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22514271
15.
Inotuzumab ozogamicin in B-cell precursor acute lymphoblastic leukemia: efficacy, toxicity, and practical considerations.
Front Immunol
; 14: 1237738, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37600823
16.
Needle in a haystack or elephant in the room? Identifying germline predisposition syndromes in the setting of a new myeloid malignancy diagnosis.
Leukemia
; 37(8): 1589-1599, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37393344
17.
Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults.
Transplant Cell Ther
; 29(5): 305-310, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736781
18.
The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL.
Transplant Cell Ther
; 29(5): 311.e1-311.e7, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36809824
19.
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia.
Leukemia
; 37(1): 53-60, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36310183
20.
Acute myeloid leukemia in SRP54-mutated congenital neutropenia.
EJHaem
; 3(2): 521-525, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846055